The SEC novel ETF debate looks like a case of narrative running ahead of evidence. Grayscale, a16z, and CCI want the SEC to avoid lumping novel exchange-traded products into one restrictive category. That is a process request, not a policy win. Meanwhile the actual flow picture is mixed: Bitcoin ETFs just had their best month of 2026 with BTC up about 25% in August, yet BlackRock's IBIT drove a $236 million single-day outflow. XRP ETFs pulled in $170 million over eleven days, and Ether ETFs turned positive YTD at $732 million. So demand is real but uneven. Catalyst: clearer SEC review routes could broaden product access. Risk: the SEC uses the comment period to formalize stricter rules anyway. Falsifier: if ETF inflows keep diverging from price, the regulatory narrative is not the binding constraint. Watch the rulemaking language, not the headlines.